Cargando…
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
Neuroendocrine carcinomas (NEC) of the pancreas are defined by a mitotic count > 20 mitoses/10 high power fields and/or Ki67 index > 20%, and included all the tumors previously classified as poorly differentiated endocrine carcinomas. These latter are aggressive malignancies with a high propen...
Autores principales: | Crippa, Stefano, Partelli, Stefano, Belfiori, Giulio, Palucci, Marco, Muffatti, Francesca, Adamenko, Olga, Cardinali, Luca, Doglioni, Claudio, Zamboni, Giuseppe, Falconi, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143761/ https://www.ncbi.nlm.nih.gov/pubmed/28018101 http://dx.doi.org/10.3748/wjg.v22.i45.9944 |
Ejemplares similares
-
Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019) -
The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020) -
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021) -
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making
por: Marchegiani, Giovanni, et al.
Publicado: (2022) -
Surgical management of pancreatic neuroendocrine neoplasms
por: Partelli, Stefano, et al.
Publicado: (2014)